Free Access
Issue
J Extra Corpor Technol
Volume 37, Number 3, September 2005
Page(s) 272 - 277
DOI https://doi.org/10.1051/ject/200537272
Published online 15 September 2005
  1. Sablotzki A, Dehne M, Welters I, et al. Alterations of the cytokine network in patients undergoing cardiopulmonary bypass. Perfusion. 1997;12:393–403. [CrossRef] [PubMed] [Google Scholar]
  2. Hall R, Smith M, Rocker G. The systemic inflammatory response to cardiopulmonary bypass: Pathophysiological, therapeutic, and pharmacological considerations. Anesthesia. 1997;85:766–82. [Google Scholar]
  3. Butler J, Pillai R, Rocker G, et al. Effect of CPB on systemic release of neutrophil elastase and tumore necrosis factor. J Thorac Cardiovasc Surg. 1993;105:25–30. [CrossRef] [Google Scholar]
  4. Casey LC. Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. Ann Thorac Surg. 1993;56:92–6. [Google Scholar]
  5. Sablotzki A, Friedrich I, Muhling J, et al. The systemic inflammatory response syndrome folowing cardiac surgery: Different expression of proinflammatory cytokines and procalcitonin in patients with and without multiorgan dysfunctions. Perfusion. 2002;17:103–9. [CrossRef] [PubMed] [Google Scholar]
  6. Khabar K, ElBarbary MA, Khouqeer F, et al. Circulating endotoxin and cytokines after cardiopulmonary bypass: Differential correlation with duration of bypass and systemic inflammatory response/multiple organ dysfunction syndromes. Clin Immunol Immunopathol. 1997;85:97–103. [CrossRef] [Google Scholar]
  7. Casey LC. Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. Ann Thorac Surg. 1993;56:92–6. [Google Scholar]
  8. Conti V. Pulmonary injury after cardiopulmonary bypass. Chest. 2001;119:2–4. [CrossRef] [PubMed] [Google Scholar]
  9. Hennein HA, Ebba H, Rodriguez JL, et al. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg. 1994;108:626–35. [CrossRef] [Google Scholar]
  10. Wan S, Marchant A, DeSmet JM, et al. Human cytokine responses to cardiac transplantation and coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1996;111:469–77. [CrossRef] [Google Scholar]
  11. Wan S, DeSmet JM, Barvais L, et al. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thor Cardiovasc Surg. 1996;112:806–11. [CrossRef] [Google Scholar]
  12. Kotani N, Hashimoto H, Sessler D, et al. Cardiopulmonary bypass produces greater pulmonary than systemic proinflammatory cytokines. Anesthesia and Analgesia. 2000;90:1039–45. [CrossRef] [PubMed] [Google Scholar]
  13. Karube N, Adachi R, Ichikawa Y, et al. Measurement of cytokine levels by coronary sinus blood sampling during cardiac surgery with cardiopulmonary bypass. ASAIO. 1996;42:787–91. [Google Scholar]
  14. Massoudy P, Zahler S, Becker B, et al. Evidence for inflammatory responses of the lungs during coronary artery bypass grafting with cardiopulmonary bypass. Chest. 2001;119:31–6. [CrossRef] [PubMed] [Google Scholar]
  15. Nandate K, Vuylsyeke A, Crosbie A, et al. Cerebrovascular cytokine responses during coronary artery bypass surgery: specific production of interlukin-8 and its attenuation by hypothermic cardiopulmonary bypass. Anesthesia. 1999;89:823–8. [Google Scholar]
  16. Picone AL, Lutz CJ, Finck C, et al. Multiple sequential insults cause post-pump syndrome. Ann Thorac Surg. 1999;67:978–85. [CrossRef] [Google Scholar]
  17. Steinberg J, Fink G, Picone A, et al. Evidence of increased metalloproteinase-9 concentration in patients following cardiopulmonary bypass. J Extra Corpor Technol. 2001;33:218–22. [Google Scholar]
  18. Groeneveld ABJ, Tacx AN, Bossink AWJ, et al. Circulating inflammatory mediators predict shock and mortality in febrile patients with microbial infection. Clin Immunol. 2003;106:106–15. [CrossRef] [Google Scholar]
  19. Darling E, Searles B, Nasrallah F, et al. High-volume, zero balanced ultrafiltration improves pulmonary function in a model of post-pump syndrome. J Extra Corpor Technol. 2002;34:254–9. [Google Scholar]
  20. Carney DE, Lutz CJ, Picone AL, et al. Matrix metalloproteinase inhibitor prevents acute lung injury after cardiopulmonary bypass. Circulation. 1999;100:400–6. [CrossRef] [PubMed] [Google Scholar]
  21. Larmann J, Theilmeier G. Inflammatory response to cardiac surgery: Cardiopulmonary bypass versus non-cardiopulmonary bypass surgery. Best Pract Res Clin Anaesthesiol. 2004;18:425–38. [CrossRef] [Google Scholar]
  22. Rubens FD, Mesana T. The inflammatory response to cardiopulmonary bypass: A therapeutic overview. Perfusion. 2004;19(Suppl 1):S5–12. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.